Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CASP1 | P29466 | 2/20 | 0.50 |
| ▸ | CASP7 | P55210 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 3/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 2/20 | 0.45 |
| ▸ | DRD4 | P21917 | 1/20 | 0.45 |
| ▸ | DRD5 | P21918 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29445708 | 1.00 | PRCP (0.59) | PRCPKDM4EALDH1A1GLAHPGD | |
| SCHEMBL28301870 | 1.00 | PRCP (0.59) | PRCPKDM4EALDH1A1GLAHPGD | |
| SCHEMBL5550983 | 0.78 | GRIN1 (0.45) | PRCP | |
| SCHEMBL811761 | 0.78 | PRCP (0.61) | PRCPDRD2DRD1DRD4DRD5 | |
| SCHEMBL8021507 | 0.78 | PRCP (0.61) | PRCPDRD2DRD1DRD4DRD5 | |
| SCHEMBL28260844 | 0.78 | PRCP (0.61) | PRCPDRD2OPRM1OPRK1DRD1 | |
| SCHEMBL8023492 | 0.78 | PRCP (0.61) | PRCPDRD2DRD1DRD4DRD5 | |
| SCHEMBL18648334 | 0.77 | PRCP (0.59) | PRCPDRD2OPRM1OPRK1DRD1 | |
| Bromide SCHEMBL4739390 | 0.77 | GRIN1 (0.44) | PRCP | |
| SCHEMBL4757289 | 0.77 | PRCP (0.59) | PRCPDRD2OPRM1OPRK1DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132388-A1 | LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | NOVOZYMES A/S (DK) | 2026-05-14 | — | — | US | disclosed |
| EP-4717756-A2 | LIPASE VARIANTS AND DETERGENT COMPOSITIONS | Novozymes A/S (DK) | 2026-04-01 | — | — | EP | disclosed |
| US-12559736-B2 | Lipase variants and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2026-02-24 | — | — | US | disclosed |
| US-12529017-B2 | Detergent composition comprising a lipase | NOVOZYMES A/S (DK) | 2026-01-20 | — | — | US | disclosed |
| US-20250382594-A1 | METHODS OF REDUCING ODOR | NOVOZYMES A/S (DK) | 2025-12-18 | — | — | US | disclosed |
| US-12492387-B2 | Lipase variants and microcapsule compositions comprising such lipase variants | NOVOZYMES A/S (DK) | 2025-12-09 | — | — | US | disclosed |
| US-20250368924-A1 | LIPASE VARIANTS AND COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | NOVOZYMES A/S (DK) | 2025-12-04 | — | — | US | disclosed |
| US-12480107-B2 | Lipase variants and the use thereof | NOVOZYMES A/S (DK) | 2025-11-25 | — | — | US | disclosed |
| US-12480108-B2 | Methods of reducing odor | Novozyms A/S (DK) | 2025-11-25 | — | — | US | disclosed |
| EP-3688150-B1 | LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | NOVOZYMES AS (DK) | 2025-06-18 | — | — | EP | disclosed |
| WO-2008007319-A2 | A COMPOSITION COMPRISING A CELLULASE AND A BLEACH CATALYST | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-17 | — | — | WO | disclosed |
| US-20070173430-A1 | Composition comprising a lipase and a bleach catalyst | THE PROCTER & GAMBLE COMPANY | 2007-07-26 | — | — | US | disclosed |
| US-20070173429-A1 | Composition comprising a lipase and a bleach catalyst | THE PROCTER & GAMBLE COMPANY | 2007-07-26 | — | — | US | disclosed |
| WO-2007083276-A1 | A COMPOSITION COMPRISING A PRE-FORMED PEROXYACID AND A BLEACH CATALYST | THE PROCTER & GAMBLE COMPANY (US) | 2007-07-26 | — | — | WO | disclosed |
| US-20070173428-A1 | Composition comprising a pre-formed peroxyacid and a bleach catalyst | THE PROCTER & GAMBLE COMPANY | 2007-07-26 | — | — | US | disclosed |
| EP-1811014-A1 | A composition comprising a pre-formed peroxyacid and a bleach catalyst | The Procter and Gamble Company (US) | 2007-07-25 | — | — | EP | disclosed |
| US-20070123440-A1 | Stable odorant systems | THE PROCTER & GAMBLE COMPANY | 2007-05-31 | — | — | US | disclosed |
| US-20070123441-A1 | Stable odorant systems | PROCTER & GAMBLE COMPANY, THE | 2007-05-31 | — | — | US | disclosed |
| WO-2007060645-A2 | STABLE ODORANT SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |
| US-20050159327-A1 | Organic catalyst system | THE PROCTER & GAMBLE COMPANY | 2005-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559736-B2 | Lipase variants and polynucleotides encoding same | LPL, PNLIP, LIPG | PRCP 1095/4885KDM4E 1861/4885ALDH1A1 3681/4885 |
| US-20260132388-A1 | LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | LIPE, LPL, PNLIP | PRCP 999/4885KDM4E 774/4885ALDH1A1 3173/4885 |
| US-12529017-B2 | Detergent composition comprising a lipase | MGLL, LPL, LIPC | PRCP 1184/4885KDM4E 1907/4885ALDH1A1 2525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.